Newsfeed
HIV Antiviral Recalled
12/28/2018
Cipla is recalling 4800 bottles of nevirapine extended-release tablets, 400 mg, because samples failed dissolution specifications, according to the December 26, 2018, US Food and Drug Administration (FDA) Enforcement Report.
The recalled affects 30-count bottles (NDC 69097-403-02) from lot GG80257 (Exp. 12/19). The recalled bottles were distributed within the United States.
Cipla voluntarily initiated the recall December 14, 2018. The FDA had not classified the recall at the time of the enforcement report.
Nevirapine is a prescription antiviral medication used to slow the progression of human immunodeficiency virus (HIV) in patients.
—Jolynn Tumolo
For more Pharmacy Learning Network articles, visit the homepage
